CASE Op-Ed: The GOP Tax Bill’s Hidden Consumer Tax
http://bit.ly/2C2BPII By Matthew Kandrach President, CASE December 13, 2017 With the Senate tax bill passing after an all-night vote-a-rama of handwritten additions and...
CASE Op-ed: Yes, Republicans May Blow Historic Tax Reform
Matthew Kandrach President, CASE ___________________________________________ bit.ly/2BDecao Earlier this week, the Senate Budget Committee voted to approve tax reform legislation, advancing...
CASE Oped: Pro-Consumer Tax Reform Lowers Rates for Everybody
DailyCaller.com by Matthew Kandrach, President With true game-changing tax reform one step closer to the finish line with the...
CASE Op-ed: Limiting Interest Payment Deduction Will Only Hurt Consumers
Morning Consult October 6, 2017 If you thought Congress’s performance over the failed attempt to repeal Obamacare made Hamlet look...
CASE Statement on President’s Tax Reform Proposal
Today CASE – Consumer Action for a Strong Economy – the nation’s preeminent free-market consumer advocacy organization, issued the following...
Congress is Holding Consumers Hostage with Border Adjustment Tax
The highly controversial Border Adjustment Tax (BAT) remains a centerpiece of House GOP leaders’ plan to enact historic tax reform....
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/